1.Research Areas and Trends in Articles on Pediatric and Adolescent Tuberculosis in Korea
Ho Yoon LIM ; Jung Hyun LEE ; Yu Jin JUNG ; Chi Eun OH
Pediatric Infection & Vaccine 2019;26(2):89-98
PURPOSE: Despite the decline in tuberculosis (TB) incidence and mortality rates in the Republic of Korea through a national TB control program, TB remains one of the most critical infectious diseases in Korean children. We investigated the trends and research areas of published articles on TB in Korean children and adolescents. METHODS: In 6 Korean and overseas databases, we searched titles and abstracts including “tuberculo*” or “TB,” “child*” or “adolescen*” or “neonat*” or “infant*” or “pediatric*,” and “korea*.” The publication type, publication year, research areas, journal title, and research subjects were analyzed. RESULTS: Out of the 257 searched documents, 120 papers were included in the analysis. Of these, 82 were original articles (68.3%), 33 case reports (27.5%), 4 review articles (3.3%), and 1 guideline (0.8%). In the original articles, the most common subject of studies was the clinical characteristics of patients with TB (36.6%), followed by diagnostics (29.3%), contact investigations (9.8%), epidemiology (6.1%), treatment (4.9%), vaccine (3.6%), latent TB infection (3.6%), complications (3.6%), and surveys on perception of TB (2.4%). From 1962, 4 articles were published in the 1960s, 10 articles in the 1970s, 11 articles in the 1980s, 22 articles in the 1990s, 26 articles in the 2000s, and 47 articles since 2010. CONCLUSIONS: The amount of research on TB in Korean children has increased over the past 5 decades; however, it has mainly focused on the clinical characteristics and diagnostics. Research in different areas, such as treatment and vaccine, is needed in the future.
Adolescent
;
Child
;
Communicable Diseases
;
Epidemiology
;
Humans
;
Incidence
;
Korea
;
Mortality
;
Publications
;
Republic of Korea
;
Research Subjects
;
Tuberculosis
2.Revised (2018) COPD Clinical Practice Guideline of the Korean Academy of Tuberculosis and Respiratory Disease: A Summary.
Yong Bum PARK ; Chin Kook RHEE ; Hyoung Kyu YOON ; Yeon Mok OH ; Seong Yong LIM ; Jin Hwa LEE ; Kwang Ha YOO ; Joong Hyun AHN
Tuberculosis and Respiratory Diseases 2018;81(4):261-273
Chronic obstructive pulmonary disease (COPD) results in high morbidity and mortality among patients nationally and globally. The Korean clinical practice guideline for COPD was revised in 2018. The guideline was drafted by the members of the Korean Academy of Tuberculosis and Respiratory Diseases as well as the participating members of the Health Insurance Review and Assessment Service, Korean Physicians' Association, and Korea Respiration Trouble Association. The revised guideline encompasses a wide range of topics, including the epidemiology, diagnosis, assessment, monitoring, management, exacerbation, and comorbidities of COPD in Korea. We performed systematic reviews assisted by an expert in meta-analysis to draft a guideline on COPD management. We expect this guideline to facilitate the treatment of patients with respiratory conditions by physicians as well other health care professionals and government personnel in South Korea.
Comorbidity
;
Delivery of Health Care
;
Diagnosis
;
Epidemiology
;
Humans
;
Insurance, Health
;
Korea
;
Mortality
;
Pulmonary Disease, Chronic Obstructive*
;
Respiration
;
Tuberculosis*
3.Nosocomial Infection Surveillance in a Tuberculosis Specialized Hospital in China.
Zhong Yao XIE ; Guo Fang HUANG ; Hui GAO ; Yu Qing CHI ; Yan Xia WANG ; Yu PANG ; Jing Ping WANG
Biomedical and Environmental Sciences 2017;30(9):691-694
Nosocomial infections (NIs) are a critical issue affecting the quality of healthcare. In this study, we performed a retrospective study to explore the incidence rates, mortality rates, and microbial spectrum of NIs in Beijing Chest Hospital, a tuberculosis (TB) specialized hospital in China. Our data demonstrate that the overall incidence rate of inpatients with NIs slightly decreased from 2012 to 2016, which may be associated with the implementation of hand hygiene measures, while the mortality rates associated with NI did not significantly change. In addition, the species distribution of NIs was quite different from that presented in previous reports, and Klebsiella pneumoniae was the most frequently isolated microorganism.
Bacteria
;
classification
;
isolation & purification
;
Beijing
;
Cross Infection
;
epidemiology
;
microbiology
;
mortality
;
Hospitals, Chronic Disease
;
Humans
;
Infection Control
;
Population Surveillance
;
Retrospective Studies
;
Tuberculosis
;
epidemiology
;
therapy
4.Trend of Bacteria and Fungi Isolated from Cerebrospinal Fluid Culture in a Tertiary Care Hospital During Recent Two Decades (1997-2016).
Su Geun LEE ; Minwoo KIM ; Gyu Yel HWANG ; Gilsung YOO ; Young UH
Annals of Clinical Microbiology 2017;20(4):81-89
BACKGROUND: Meningitis is a clinically important disease because of its high mortality and morbidity. The epidemiology of this disease has changed remarkably due to the introduction of pneumococcal vaccines and Haemophilus influenzae type b (Hib) conjugate vaccine. Therefore, it is required to continuously monitor and research the organisms isolated from cerebrospinal fluid (CSF) cultures. METHODS: We analyzed trends of bacteria and fungi isolates obtained from CSF cultures between 1997 and 2016 in a tertiary care hospital according to year, month, gender, and age. RESULTS: Out of a total of 38,450 samples, we identified 504 (1.3%) isolates. The isolation rate in the first tested decade (1997–2006) ranged from 1.3% to 3.1%, while that in the second decade (2007–2016) ranged from 0.4% to 1.5%. The most common organisms was coagulase-negative staphylococci (CoNS) (31.9%), followed by Staphylococcus aureus (9.5%), Streptococcus pneumoniae (7.5%), Acinetobacter baumannii (5.8%), and Mycobacterium tuberculosis (5.8%). Monthly isolation rates were highest in May and July and lowest in February and December. Male to female ratio was 1.5:1. The isolation rates of S. pneumoniae, Enterococcus faecium, and Escherichia coli were similar in children and adults, but those of S. aureus, E. faecalis, A. baumannii, Pseudomonas aeruginosa, M. tuberculosis, and Cryptococcus neoformans were higher in adults than in children. CONCLUSION: During the last two decades, the isolation rate of CSF culture per year has decreased, with monthly isolation rates being highest in May and July. CoNS, S. aureus, and S. pneumoniae were most common in males, whereas CoNS, S. pneumoniae, and M. tuberculosis were most common in females. While Group B Streptococcus was most common in infants younger than 1 year, S. aureus and C. neoformans were more common in adults.
Acinetobacter baumannii
;
Adult
;
Bacteria*
;
Cerebrospinal Fluid*
;
Child
;
Cryptococcus neoformans
;
Enterococcus faecium
;
Epidemiology
;
Escherichia coli
;
Female
;
Fungi*
;
Haemophilus influenzae type b
;
Humans
;
Infant
;
Male
;
Meningitis
;
Mortality
;
Mycobacterium tuberculosis
;
Pneumococcal Vaccines
;
Pneumonia
;
Pseudomonas aeruginosa
;
Staphylococcus aureus
;
Streptococcus
;
Streptococcus pneumoniae
;
Tertiary Healthcare*
;
Tuberculosis
5.Summary of the Chronic Obstructive Pulmonary Disease Clinical Practice Guideline Revised in 2014 by the Korean Academy of Tuberculosis and Respiratory Disease.
Hyoung Kyu YOON ; Yong Bum PARK ; Chin Kook RHEE ; Jin Hwa LEE ; Yeon Mok OH
Tuberculosis and Respiratory Diseases 2017;80(3):230-240
Chronic obstructive pulmonary disease (COPD) results in high morbidity and mortality among patients both domestically and globally. The Korean clinical practice guideline for COPD was revised in 2014. It was drafted by the members of the Korean Academy of Tuberculosis and Respiratory Diseases, as well as participating members of the Health Insurance Review and Assessment Service, Korean Physicians' Association, and Korea Respiration Trouble Association. This revised guideline covers a wide range of topics, including the epidemiology, diagnosis, assessment, monitoring, management, exacerbation, and comorbidities of COPD in Korea. We drafted a guideline on COPD management by performing systematic reviews on the topic of management with the help of a meta-analysis expert. We expect this guideline will be helpful medical doctors treating patients with respiratory conditions, other health care professionals, and government personnel in South Korea.
Comorbidity
;
Delivery of Health Care
;
Diagnosis
;
Epidemiology
;
Humans
;
Insurance, Health
;
Korea
;
Mortality
;
Pulmonary Disease, Chronic Obstructive*
;
Respiration
;
Tuberculosis*
6.Clinical comparative analysis for pulmonary histoplasmosis and progressive disseminated histoplasmosis.
Yan ZHANG ; Xiaoli SU ; Yuanyuan LI ; Ruoxi HE ; Chengping HU ; Pinhua PAN
Journal of Central South University(Medical Sciences) 2016;41(12):1345-1351
To compare clinical features, diagnosis and therapeutic effect between pulmonary histoplasmosis and progressive disseminated histoplasmosis.
Methods: A retrospective analysis for 12 cases of hospitalized patients with histoplasmosis, who was admitted in Xiangya Hospital, Central South University during the time from February 2009 to October 2015, was carried out. Four cases of pulmonary histoplasmosis and 8 cases of progressive disseminated histoplasmosis were included. The differences of clinical features, imaging tests, means for diagnosis and prognosis were analyzed between the two types of histoplasmosis.
Results: The clinical manifestations of pulmonary histoplasmosis were mild, such as dry cough. However, the main clinical symptoms of progressive disseminated histoplasmosis were severe, including recurrence of high fever, superficial lymph node enlargement over the whole body, hepatosplenomegaly, accompanied by cough, abdominal pain, joint pain, skin changes, etc.Laboratory examination showed pancytopenia, abnormal liver function and abnormal coagulation function. One pulmonary case received the operation of left lower lung lobectomy, 3 cases of pulmonary histoplasmosis and 6 cases of progressive disseminated histoplasmosis patients were given deoxycholate amphotericin B, itraconazole, voriconazole or fluconazole for antifungal therapy. One disseminated case discharged from the hospital without treatment after diagnosis of histoplasmosis, and 1 disseminated case combined with severe pneumonia and active tuberculosis died ultimately.
Conclusion: As a rare fungal infection, histoplasmosis is easily to be misdiagnosed. The diagnostic criteria depends on etiology through bone marrow smear and tissues biopsy. Liposomeal amphotericin B, deoxycholate amphotericin B and itraconazole are recommended to treat infection for histoplasma capsulatum.
Abdominal Pain
;
etiology
;
Amphotericin B
;
therapeutic use
;
Antifungal Agents
;
therapeutic use
;
Biopsy
;
Cough
;
epidemiology
;
Death
;
Deoxycholic Acid
;
therapeutic use
;
Diagnostic Errors
;
Drug Combinations
;
Fever
;
etiology
;
Hepatomegaly
;
etiology
;
Histoplasma
;
Histoplasmosis
;
complications
;
diagnosis
;
mortality
;
therapy
;
Humans
;
Invasive Fungal Infections
;
complications
;
diagnosis
;
therapy
;
Itraconazole
;
therapeutic use
;
Lung
;
microbiology
;
surgery
;
Lung Diseases, Fungal
;
diagnosis
;
surgery
;
therapy
;
Pneumonia
;
complications
;
mortality
;
Recurrence
;
Retrospective Studies
;
Splenomegaly
;
etiology
;
Treatment Outcome
;
Tuberculosis
;
complications
;
mortality
7.Human Immunodeficiency Virus Infection-Associated Mortality during Pulmonary Tuberculosis Treatment in Six Provinces of China.
Yu Ji LAI ; Er Yong LIU ; Li Ming WANG ; Jamie P MORANO ; Ning WANG ; Kaveh KHOSHNOOD ; Lin ZHOU ; Shi Ming CHENG
Biomedical and Environmental Sciences 2015;28(6):421-428
OBJECTIVETo investigate the risk factors attributable to tuberculosis-related deaths in areas with human immunodeficiency virus (HIV) infection epidemics.
METHODSA prospective cohort study of newly registered patients in tuberculosis (TB) dispensaries in six representative Chinese provinces was conducted from September 1, 2009 to August 31, 2011. Risk factors for TB-associated death were identified through logistic regression analysis.
RESULTSOf 19,103 newly registered pulmonary TB patients, 925 (4.8%) were found to be HIV-positive. Miliary TB and acid-fast bacillus smear-negative TB were more common among these patients. Out of a total of 322 (1.7%) deaths that occurred during TB treatment, 85 (26%) of the patients were co-infected with HIV. Multivariate analysis revealed that HIV infection was the strongest predictor of death [adjusted odds ratio (aOR) 7.86]. Other significant mortality risk factors included presentation with miliary TB (aOR 4.10; 95% confidence interval: 2.14-7.88), ⋝35 years of age (aOR 3.04), non-Han ethnicity (aOR 1.67), and farming as an occupation (aOR 1.59). For patients with TB/HIV co-infection, miliary TB was the strongest risk factor for death (aOR 5.48). A low CD4 count (⋜200 cells/µL) (aOR 3.27) at the time of TB treatment initiation and a lack of antiretroviral therapy (ART) administration (aOR 3.78) were also correlated with an increased risk of death.
CONCLUSIONInfection with HIV was independently associated with increased mortality during TB treatment. Offering HIV testing at the time of diagnosis with TB, early TB diagnosis among HIV/acquired immunodeficiency syndrome patients, and the timely provision of ART were identified as the key approaches that could reduce the number of HIV-associated TB deaths.
Adult ; China ; epidemiology ; Cohort Studies ; Coinfection ; mortality ; therapy ; Female ; HIV Infections ; complications ; mortality ; Humans ; Male ; Middle Aged ; Risk Factors ; Tuberculosis, Pulmonary ; complications ; mortality ; therapy
8.Feature analysis on patients died from co-infection of Mycobacterium tuberculosis and human immunodeficiency virus in Guangxi, from 2007 to 2012.
Zhigang ZHENG ; Zhenzhu TANG ; Mei LIN ; Feiying LIU ; Zhezhe CUI ; Wenkui GENG
Chinese Journal of Epidemiology 2014;35(6):695-698
OBJECTIVETo understand the general feature of patients with Mycobacterium tuberculosis (MTB) and human immunodeficiency virus (HIV) co-infectious (TB/HIV) in Guangxi, from 2007 to 2012.
METHODSInformation regarding individuals that the contributory causes of death were due to MTB infection among HIV as the underlying cause of death from the Vital Registration System, together with bacterium smear or culture results, onset of TB, time that TB was diagnosed and entered an Internet base TB surveillance system was collected and checked. Data including information on time of death, age, occupation, the underlying cause of death among TB patients, bacterium distribution, average age of death, interval from onset to death, percentage of TB/HIV co-infection patients among all the patients etc, were all analysed.
RESULTS203 patients died from HIV associated with TB from the Guangxi Vital Registration System were identified between 2007 and 2012. The average percentage of TB/HIV co-infection cases accounted for 8.24% (ranging from 3.94% in 2007 to 13.27% in 2012) among all the deaths of HIV infection while it accounted for 9.90% (ranging from 2.56% to in 2007 to 26.88% in 2012) among patients with MTB infection in the same period. The average percentage of deaths from TB/HIV co-infection in 2010 and 2012 accounted for 10.66% (ranging from 8.83% to 13.27%)and 22.17% (ranging from 20.60% to 26.88%)among patients died of HIV and TB infection respectively. The male-female ratio was 4.21 for 1, with the average age of death as 44.65 (44.65 ± 15.52) years;median time from TB symptoms onset to diagnosis as 37 (mean 94.31, standard deviation 206.07) days, record as (94.31 ± 206.07); median time from diagnosis to death as 46 (165.22 ± 282.19) days, 54.68% TB/HIV patients died within two months of being diagnosed with TB and the median time from TB symptoms onset to death as 131 (257.68 ± 340.79) days. 16.26% of the TB/HIV cases were bacterium confirmed TB cases.
CONCLUSIONCompare to those TB patients without HIV, less bacterium evidence was found in TB/HIV patients. High burden caused by HIV disease was seen if they were co-infected with TB. An increasing proportion of deaths was noticed among patients co-infected with HIV and TB in the last three years, suggesting that the coverage of antiretroviral therapy be scaled up together with the strengthening of the capability on early TB case-finding among people live with HIV.
Adult ; China ; epidemiology ; Coinfection ; mortality ; Female ; HIV Infections ; microbiology ; mortality ; Humans ; Male ; Middle Aged ; Tuberculosis ; mortality ; virology ; Young Adult
9.Overview of the Burden of Diseases in North Korea.
Yo Han LEE ; Seok Jun YOON ; Young Ae KIM ; Ji Won YEOM ; In Hwan OH
Journal of Preventive Medicine and Public Health 2013;46(3):111-117
This article evaluates the overall current disease burden of North Korea through the recent databases of international organizations. It is notable that North Korea as a nation is exhibiting a relatively low burden from deaths and that there is greater burden from deaths caused by non-communicable diseases than from those caused by communicable diseases and malnutrition. However, the absolute magnitude of problems from communicable diseases like TB and from child malnutrition, which will increase the disease burden in the future, remains great. North Korea, which needs to handle both communicable and nutritional conditions, and non-communicable diseases, whose burden is ever more increasing in the nation, can now be understood as a country with the 'double-burden' of disease.
Adolescent
;
Adult
;
Aged
;
Child
;
Child Nutrition Disorders/epidemiology
;
Child, Preschool
;
Communicable Diseases/epidemiology/*mortality
;
Databases, Factual
;
Democratic People's Republic of Korea
;
Humans
;
Incidence
;
Middle Aged
;
Nutritional Status
;
Tuberculosis/epidemiology/mortality
;
Young Adult
10.Incidence and Risk Factors of Tuberculosis in Patients with Human Immunodeficiency Virus Infection.
Jeong Hwan HWANG ; Pyoeng Gyun CHOE ; Nak Hyun KIM ; Ji Hwan BANG ; Kyoung Ho SONG ; Wan Beom PARK ; Eu Suk KIM ; Sang Won PARK ; Hong Bin KIM ; Nam Joong KIM ; Myoung Don OH ; Kang Won CHOE
Journal of Korean Medical Science 2013;28(3):374-377
Korea is a low prevalence country for human immunodeficiency virus (HIV) infection and has an intermediate tuberculosis (TB) burden. We previously reported that the incidence of TB in HIV-infected patients was 9.6 cases per 100 person-years (P-Y) between 1988 and 1997. The aims of the present study were to measure any change in incidence from the previous study, and to identify risk factors for TB in HIV-infected patients. We reviewed all medical records of HIV-infected patients who were followed-up in one tertiary hospital between 1998 and 2010. Over the total observation period of 5858.33 P-Y, TB developed in 70 patients (1.19 cases per 100 P-Y; 95% confidence interval [CI], 0.91-1.47 cases per 100 P-Y). Based on Poisson regression, one risk factor associated with TB was an initial CD4+ cell count below 200 cells/microliter (relative risk, 2.34; 95% CI, 1.47-3.73). Mean CD4+ cell counts of pulmonary, extrapulmonary, and both pulmonary and extrapulmonary TB were 179.8 cells/microliter, 138.3 cells/microliter, and 114.2 cells/microliter, respectively (P = 0.55). In conclusion, the incidence of TB in HIV-infected patients has decreased since the previous study. An initial CD4+ cell count below 200 cells/microliter is an independent risk factor for development of TB in HIV-infected patients.
Adult
;
CD4 Lymphocyte Count
;
Female
;
HIV Infections/*complications
;
Humans
;
Incidence
;
Male
;
Middle Aged
;
Retrospective Studies
;
Risk Factors
;
Tuberculosis/complications/*epidemiology/mortality

Result Analysis
Print
Save
E-mail